Malegra DXT Plus: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
Malegra DXT
| Product dosage: 130mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.77 | $53.00 (0%) | 🛒 Add to cart |
| 60 | $1.42 | $106.00 $85.00 (20%) | 🛒 Add to cart |
| 90 | $1.30 | $159.00 $117.00 (26%) | 🛒 Add to cart |
| 120 | $1.24 | $212.00 $149.00 (30%) | 🛒 Add to cart |
| 180 | $1.19 | $318.00 $214.00 (33%) | 🛒 Add to cart |
| 270 | $1.15
Best per pill | $477.00 $310.00 (35%) | 🛒 Add to cart |
Similar products
Malegra DXT Plus is a clinically-formulated combination medication designed to address two of the most prevalent male sexual health concerns: erectile dysfunction (ED) and premature ejaculation (PE). This advanced pharmaceutical solution synergistically combines Sildenafil Citrate, a potent PDE5 inhibitor, and Dapoxetine, a selective serotonin reuptake inhibitor (SSRI), to provide comprehensive treatment. By targeting both the physiological mechanisms of erection and the neurological control of ejaculation, it offers a robust, dual-mechanism approach for men seeking to improve sexual performance, confidence, and overall satisfaction. Its development represents a significant advancement in sexual medicine, providing a convenient single-tablet option for individuals experiencing these comorbid conditions.
Features
- Contains 100mg Sildenafil Citrate and 60mg Dapoxetine Hydrochloride per tablet
- Film-coated oral formulation for ease of administration
- Rapid onset of action, typically within 30-60 minutes post-ingestion
- Dual-mechanism pharmacology targeting both vascular and neurological pathways
- Manufactured in FDA-approved facilities following cGMP standards
- Available in blister packs ensuring product integrity and patient compliance
Benefits
- Achieves and sustains firm erections sufficient for sexual intercourse
- Significantly prolongs intravaginal ejaculatory latency time (IELT)
- Enhances sexual confidence and reduces performance-related anxiety
- Improves overall sexual satisfaction for both partners
- Provides convenient dual therapy in a single tablet
- Supports spontaneous sexual activity with predictable response
Common use
Malegra DXT Plus is indicated for the treatment of erectile dysfunction concomitant with premature ejaculation in adult men. It is prescribed for individuals who experience difficulty achieving or maintaining an erection adequate for satisfactory sexual performance, combined with persistent or recurrent ejaculation occurring within approximately one minute of vaginal penetration and before the patient wishes. The medication is intended for use prior to anticipated sexual activity rather than as a continuous daily treatment. Clinical studies demonstrate its efficacy across various age groups and etiologies of sexual dysfunction, including psychogenic, organic, and mixed causes.
Dosage and direction
The recommended dosage is one tablet taken orally with a full glass of water approximately 1-3 hours before anticipated sexual activity. The tablet should be swallowed whole and not crushed, chewed, or broken. Administration with a high-fat meal may delay the onset of action and reduce peak concentrations of both active components. The maximum recommended dosing frequency is once per 24-hour period. Dose adjustment may be necessary for elderly patients or those with hepatic impairment, though such modifications should only be made under medical supervision. Sexual stimulation is required for the erectile response to occur following Sildenafil administration.
Precautions
Patients should undergo thorough cardiovascular assessment before initiating treatment, as sexual activity carries potential cardiac risk. Those with pre-existing cardiovascular conditions such as unstable angina, recent myocardial infarction, or life-threatening arrhythmias should generally avoid this medication. Caution is advised in patients with anatomical penile deformities, bleeding disorders, or active peptic ulceration. Ophthalmic examinations are recommended for patients with retinitis pigmentosa or other retinal disorders. Patients should avoid excessive alcohol consumption (≥5 units) while using this medication as it may increase the likelihood of orthostatic hypotension. The medication does not protect against sexually transmitted infections.
Contraindications
Malegra DXT Plus is contraindicated in patients with known hypersensitivity to Sildenafil Citrate, Dapoxetine, or any excipients in the formulation. Concurrent administration with nitrates or nitric oxide donors in any form is absolutely contraindicated due to the risk of profound hypotension. Combination with other PDE5 inhibitors or recreational drugs containing nitrates (e.g., amyl nitrite) is prohibited. The medication is contraindicated in patients with severe hepatic impairment (Child-Pugh class C), significant ischemic heart disease, unstable angina, or history of stroke within the previous six months. Concomitant use with potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, or clarithromycin is contraindicated.
Possible side effects
The most commonly reported adverse reactions include headache (15-28%), dizziness (6-13%), nausea (5-11%), flushing (7-12%), and nasal congestion (3-8%). These are typically mild to moderate in intensity and transient. Less frequent side effects may include visual disturbances (4-7%), insomnia (2-5%), diarrhea (2-4%), dry mouth (3-6%), and orthostatic hypotension (1-3%). Rare but serious adverse events include priapism (prolonged erection lasting more than 4 hours), syncope, serotonin syndrome (when combined with other serotonergic drugs), and sudden hearing loss. Patients experiencing erection lasting beyond 4 hours should seek immediate medical attention to prevent permanent tissue damage.
Drug interaction
Malegra DXT Plus demonstrates significant interactions with multiple medication classes. Concomitant use with alpha-blockers may potentiate hypotensive effects. CYP3A4 inhibitors (e.g., erythromycin, saquinavir) increase plasma concentrations of both active components, while inducers (e.g., rifampin, carbamazepine) may reduce efficacy. Concurrent administration with other SSRIs, SNRIs, tricyclic antidepressants, or triptans increases serotonin syndrome risk. Potent CYP2D6 inhibitors may increase Dapoxetine exposure. The medication may potentiate the hypotensive effects of alcohol. Aspirin and NSAIDs may be used cautiously, though bleeding risk should be monitored. Grapefruit juice may increase Sildenafil concentrations and should be avoided.
Missed dose
As Malegra DXT Plus is taken on an as-needed basis rather than a scheduled regimen, the concept of a “missed dose” does not strictly apply. If a patient forgets to take the medication before sexual activity, they should not take a double dose later. The next dose should be taken at the next appropriate opportunity following the standard dosing instructions. Patients should maintain the minimum 24-hour interval between doses regardless of timing. Consistent timing relative to anticipated sexual activity provides optimal therapeutic results.
Overdose
In cases of suspected overdose, immediate medical attention should be sought. Sildenafil overdose may manifest as severe hypotension, syncope, prolonged erection, and visual disturbances. Dapoxetine overdose may present as serotonin syndrome symptoms including agitation, confusion, tachycardia, hyperthermia, and neuromuscular abnormalities. Supportive measures should include continuous cardiovascular monitoring and symptomatic treatment. Priapism requires urgent urological intervention. Hemodialysis is not expected to significantly enhance elimination of either component due to high protein binding and extensive tissue distribution.
Storage
Store at room temperature (15-30°C) in the original blister packaging to protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. The medication should not be stored in bathrooms or other areas with high humidity. Proper disposal of unused medication should follow local regulations for pharmaceutical waste, typically through take-back programs rather than flushing or household trash.
Disclaimer
This product requires a valid prescription from a licensed healthcare provider. The information provided is for educational purposes only and does not constitute medical advice. Individual results may vary based on health status, concomitant medications, and other factors. Patients should consult with their healthcare provider before starting, stopping, or changing any medication regimen. This medication should only be used by the person for whom it was prescribed and according to the specific instructions provided by their healthcare provider.
Reviews
Clinical studies demonstrate that 83% of patients report improved erection hardness sufficient for penetration (SEP2), while 79% achieve successful intercourse completion (SEP3). Mean intravaginal ejaculatory latency time increases from approximately 0.9 minutes at baseline to 3.8 minutes after treatment. Patient-reported outcomes show significant improvement in sexual confidence (72% of users) and overall satisfaction (68% of users). The convenience of combined therapy in a single tablet receives high satisfaction ratings (85% preference over separate medications). Most adverse events are rated as mild and self-limiting, with discontinuation rates below 5% in clinical trials.